DD125605A5 - - Google Patents

Info

Publication number
DD125605A5
DD125605A5 DD192654A DD19265476A DD125605A5 DD 125605 A5 DD125605 A5 DD 125605A5 DD 192654 A DD192654 A DD 192654A DD 19265476 A DD19265476 A DD 19265476A DD 125605 A5 DD125605 A5 DD 125605A5
Authority
DD
German Democratic Republic
Application number
DD192654A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD125605A5 publication Critical patent/DD125605A5/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DD192654A 1975-05-27 1976-05-03 DD125605A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/581,314 US4062933A (en) 1975-05-27 1975-05-27 Colloidal compositions with protective agents suitable for radioactive labeling

Publications (1)

Publication Number Publication Date
DD125605A5 true DD125605A5 (xx) 1977-05-04

Family

ID=24324705

Family Applications (1)

Application Number Title Priority Date Filing Date
DD192654A DD125605A5 (xx) 1975-05-27 1976-05-03

Country Status (11)

Country Link
US (1) US4062933A (xx)
JP (1) JPS51144717A (xx)
AT (1) AT350191B (xx)
BE (1) BE842252A (xx)
DD (1) DD125605A5 (xx)
DE (1) DE2617922C3 (xx)
FR (1) FR2361866A1 (xx)
GB (2) GB1530192A (xx)
IT (1) IT1062236B (xx)
NL (1) NL7605273A (xx)
SE (2) SE430568B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4233284A (en) * 1978-03-31 1980-11-11 The Procter & Gamble Company Stabilized radiographic scanning agents
US4232000A (en) * 1978-06-28 1980-11-04 The Procter & Gamble Company Radioactive scanning agents with stabilizer
US4229427A (en) * 1978-06-28 1980-10-21 The Procter & Gamble Company Radioactive scanning agents with hydroquinone stabilizer
US4358434A (en) * 1979-12-19 1982-11-09 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
US4390517A (en) * 1979-12-19 1983-06-28 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
EP0045817B1 (en) * 1980-08-11 1987-05-13 E.I. Du Pont De Nemours And Company Denatured albumin complexes for radioscintigraphic imaging and evaluation of reticuloendothelial systems
IT1194135B (it) * 1981-01-05 1988-09-14 Novo Industri As Composizioni di plasmina stabilizzata e metodo per la loro preparazione
DE3331159A1 (de) * 1983-08-30 1985-03-14 Hoechst Ag, 6230 Frankfurt N-(4-aminobenzoyl)-aminodicarbonsaeuren zur stabilisierung von technetium-99m-praeparaten, stabilisierte injektionspraeparate und verfahren zu ihrer herstellung
US4931385A (en) * 1985-06-24 1990-06-05 Hygeia Sciences, Incorporated Enzyme immunoassays and immunologic reagents
DE3728599A1 (de) * 1986-12-10 1988-06-23 Hoechst Ag Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz
US5102788A (en) * 1988-11-21 1992-04-07 Hygeia Sciences, Inc. Immunoassay including lyophilized reactant mixture
CA1340250C (en) * 1989-09-18 1998-12-15 Hans J. Hansen Method for rapidly radiolabeling monovalent antibody fragments with technetium
DE4017439C2 (de) * 1990-05-30 1994-06-23 Deutsches Krebsforsch Polyethersubstituierte Tumormittel
US5219556A (en) * 1990-07-09 1993-06-15 Mallinckrodt Medical, Inc. Stabilized therapeutic radiopharmaceutical complexes
JP4557098B2 (ja) * 1999-03-31 2010-10-06 味の素株式会社 安定な６−アミジノ−２−ナフチル４−グアニジノベンゾエート酸付加塩製剤ならびにその製造方法
US6902718B2 (en) * 2000-10-24 2005-06-07 Diatide, Inc. Stabilization of radiopharmaceutical compositions using hydrophilic thioethers
US6989138B2 (en) 2000-10-24 2006-01-24 Diatide, Inc. Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans
US6881396B2 (en) * 2000-10-24 2005-04-19 Diatide, Inc. Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy-chromans

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1517787A1 (de) * 1965-12-06 1970-01-29 Takeda Chemical Industries Ltd Enzympraeparat und Verfahren zu seiner Herstellung
US3674900A (en) * 1967-01-03 1972-07-04 Lloyd M Thompson Radioactive macroaggregates of serum albumin
US3683066A (en) * 1969-01-14 1972-08-08 Ivan Ascanio Technetium 99m colloidal composition
US3810976A (en) * 1970-05-20 1974-05-14 Univ Oklahoma Foundation Inc Lung scanning 99m technetium macroaggregate and method of preparation
CA958339A (en) * 1970-09-19 1974-11-26 Yoshio Yoshimura Stabilization of microorganism cells lytic enzyme
BE786566A (fr) * 1971-07-20 1973-01-22 Squibb & Sons Inc Agregats a base de tc-99m et d'albumine

Also Published As

Publication number Publication date
JPS51144717A (en) 1976-12-13
JPS5610889B2 (xx) 1981-03-11
SE8006059L (sv) 1980-08-29
AT350191B (de) 1979-05-10
AU1421376A (en) 1978-08-31
BE842252A (fr) 1976-09-16
FR2361866A1 (fr) 1978-03-17
DE2617922A1 (de) 1976-12-09
GB1530194A (en) 1978-10-25
SE430568B (sv) 1983-11-28
ATA303576A (de) 1978-10-15
FR2361866B1 (xx) 1978-12-15
SE438093B (sv) 1985-04-01
IT1062236B (it) 1983-09-20
DE2617922C3 (de) 1982-03-25
SE7606035L (sv) 1976-11-28
US4062933A (en) 1977-12-13
NL7605273A (nl) 1976-11-30
GB1530192A (en) 1978-10-25
DE2617922B2 (de) 1979-10-31

Similar Documents

Publication Publication Date Title
FR2324218B1 (xx)
FR2328564B1 (xx)
JPS5339650B2 (xx)
JPS5760114B2 (xx)
JPS5717077Y2 (xx)
JPS558945Y2 (xx)
JPS5292703U (xx)
JPS5282315U (xx)
JPS51145874U (xx)
JPS51117757U (xx)
CH589805A5 (xx)
CH586475A5 (xx)
CH596890A5 (xx)
CH601969A5 (xx)
CH596038A5 (xx)
CH595999A5 (xx)
CH595873A5 (xx)
CH597411A5 (xx)
CH595668A5 (xx)
CH595566A5 (xx)
CH594877A5 (xx)
CH594604A5 (xx)
CH593508B5 (xx)
CH590391A5 (xx)
CH597672A5 (xx)